Bayer SG&A Expenses 2012-2025 | BAYRY

Bayer sg&a expenses for the twelve months ending December 31, 2025 were $16.642B, a 3.51% decline year-over-year.

  • Bayer annual sg&a expenses for 2025 were $16.642B, a 3.51% decline from 2024.
  • Bayer annual sg&a expenses for 2024 were $17.247B, a 6.7% increase from 2023.
  • Bayer annual sg&a expenses for 2023 were $16.164B, a 9.34% decline from 2022.

Bayer SG&A Expenses 2012-2025 | BAYRY

  • Bayer annual sg&a expenses for 2025 were $16.642B, a 3.51% decline from 2024.
  • Bayer annual sg&a expenses for 2024 were $17.247B, a 6.7% increase from 2023.
  • Bayer annual sg&a expenses for 2023 were $16.164B, a 9.34% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Innoviva (INVA)$1.8B